Visalytics
Visalytics
approved EB-2 (NIW)

Senior Postdoctoral Researcher

Bioinformatics · Pakistan · 2022-04-30

Processing Time
68 days
Decision Date
2022-04-30
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on the development of state-of-the-art pipelines, algorithms, and systems to predict disease-specific biomarkers and drug effects. His work involves studying the viral microbiome, performing single-cell and epigenetic analyses of gastrointestinal tissue, and investigating noncoding RNAs related to COVID-19, inflammatory bowel disease, and liver fibrosis.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor has broad implications for the U.S. as the computational diagnostic models help address pressing public health concerns.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 7 years of experience, 12 peer-reviewed publications, and 651 citations, supported by 4 expert letters.

3 Waiver Benefit Met

The adjudicating bench was convinced of the petitioner's merit and granted the waiver without a Request for Evidence.

Why This Petition Was Approved

The petition was approved based on the petitioner's 12 peer-reviewed journal articles (3 first-authored) and 651 citations. He demonstrated 7 years of research experience and provided 4 letters of recommendation from leading experts, satisfying the Dhanasar prongs for national importance and being well-positioned.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
New Jersey 103 days 2025-07-17
The petitioner proposes to continue characterizing the genetic, molecular, and biological mechanisms underlying complex diseases such as cancer, neuronal disorders, and psychiatric conditions. Her work integrates bioinformatics, multi-omics analysis, and artificial intelligence with wet-lab validation to support early detection and personalized medical strategies.
View Case

Clinical Research Coordinator

Biotechnology · Pakistan

WeGreened EB-2 (NIW) approved
Michigan 47 days 2025-05-12
The petitioner proposes to advance disease prevention and treatment strategies, specifically focusing on inflammatory bowel disease, heart disease, autoimmune disorders, and novel infections. The work involves optimizing and synthesizing predictive, therapeutic, and diagnostic modalities to improve clinical outcomes for pressing health issues.
View Case

Research Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
93 days 2023-03-03
The petitioner proposes to refine diagnostic and therapeutic strategies for complex and chronic diseases by integrating molecular profiling, cellular modeling, and translational biomedical analysis. His work leverages multi-omics data and advanced bioanalysis to deepen the mechanistic understanding of disease progression and treatment response. The endeavor aims to translate biological discoveries into actionable improvements in precision medicine and clinical outcomes.
View Case

Research Assistant

Biotechnology · Ghana

WeGreened EB-2 (NIW) approved
California 279 days 2026-01-27
The petitioner proposes to develop data-driven computational models across molecular, individual, and population scales to improve healthcare delivery. The work focuses on connecting biological data to actionable insights for predicting pathogen evolution, treatment responses, and population-level risks. This research aims to strengthen prediction, preparedness, and response across biological systems using AI-driven analysis.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Pakistan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-30.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 68 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Pakistan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist